Advances in HER2-positive and HER2-low Breast Cancer
HTML-код
- Опубликовано: 7 окт 2024
- This one-hour interactive, online CME/CMLE module is designed to help pathologists and laboratory professionals gain a deeper scientific understanding of recent advances in the diagnosis and management of HER2-positive and HER2-low breast cancer. To claim CME credit for this course, please register at store.ascp.org.... Supported by an independent educational grant from Daiichi Sankyo, Inc.